 | • レポートコード：MRC2102QY3819 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のシクロホスファミド市場について種類別（高用量、低用量）、用途別（がん、自己免疫疾患、ALアミロイドーシス、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・シクロホスファミド市場の概要 ・世界の主要地域別シクロホスファミド市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のシクロホスファミド市場規模2015-2026：種類別（高用量、低用量） ・世界のシクロホスファミド市場規模2015-2026：用途別（がん、自己免疫疾患、ALアミロイドーシス、その他） ・シクロホスファミドの米国市場規模2015-2020 ・シクロホスファミドのヨーロッパ市場規模2015-2020 ・シクロホスファミドの中国市場規模2015-2020 ・シクロホスファミドの日本市場規模2015-2020 ・シクロホスファミドの東南アジア市場規模2015-2020 ・シクロホスファミドのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・シクロホスファミドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・シクロホスファミドの市場動向・機会・課題 ・調査の結論 |
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.
Top 8 manufacturers took 75.4% market share in 2019.
Market Analysis and Insights: Global Cyclophosphamide Market
The global Cyclophosphamide market size is projected to reach US$ 714 million by 2026, from US$ 629.2 million in 2020, at a CAGR of 2.1% during 2021-2026.
Global Cyclophosphamide Scope and Market Size
The global Cyclophosphamide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cyclophosphamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Cyclophosphamide market is segmented into
High-Dose
Low-Dose
Segment by Application, the Cyclophosphamide market is segmented into
Cancer
Autoimmune Diseases
AL Amyloidosis
Others
The Cyclophosphamide market is analysed and market size information is provided by regions (countries). Segment by Application, the Cyclophosphamide market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cyclophosphamide Market Share Analysis
Cyclophosphamide market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cyclophosphamide business, the date to enter into the Cyclophosphamide market, Cyclophosphamide product introduction, recent developments, etc.
The major vendors covered:
Baxter
Novartis
Hikma Pharmaceuticals
Amneal Pharmaceuticals LLC
Jiangsu Hengrui Medicine
NorthStar Rx LLC
GLS Pharma
CSC Pharmaceuticals International
1 Cyclophosphamide Market Overview
1.1 Cyclophosphamide Product Scope
1.2 Cyclophosphamide Segment by Type
1.2.1 Global Cyclophosphamide Sales by Type (2020-2026)
1.2.2 High-Dose
1.2.3 Low-Dose
1.3 Cyclophosphamide Segment by Application
1.3.1 Global Cyclophosphamide Sales Comparison by Application (2020-2026)
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 AL Amyloidosis
1.3.5 Others
1.4 Cyclophosphamide Market Estimates and Forecasts (2015-2026)
1.4.1 Global Cyclophosphamide Sales Growth Rate (2015-2026)
1.4.2 Global Cyclophosphamide Revenue and Growth Rate (2015-2026)
1.4.3 Global Cyclophosphamide Price Trends (2015-2026)
2 Cyclophosphamide Estimate and Forecast by Region
2.1 Global Cyclophosphamide Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Cyclophosphamide Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Cyclophosphamide Sales Market Share by Region (2015-2020)
2.2.2 Global Cyclophosphamide Revenue Market Share by Region (2015-2020)
2.3 Global Cyclophosphamide Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Cyclophosphamide Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Cyclophosphamide Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cyclophosphamide Estimates and Projections (2015-2026)
2.4.2 Europe Cyclophosphamide Estimates and Projections (2015-2026)
2.4.3 China Cyclophosphamide Estimates and Projections (2015-2026)
2.4.4 Japan Cyclophosphamide Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Cyclophosphamide Estimates and Projections (2015-2026)
2.4.6 India Cyclophosphamide Estimates and Projections (2015-2026)
3 Global Cyclophosphamide Competition Landscape by Players
3.1 Global Top Cyclophosphamide Players by Sales (2015-2020)
3.2 Global Top Cyclophosphamide Players by Revenue (2015-2020)
3.3 Global Cyclophosphamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclophosphamide as of 2019)
3.4 Global Cyclophosphamide Average Price by Company (2015-2020)
3.5 Manufacturers Cyclophosphamide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Cyclophosphamide Players (Opinion Leaders)
4 Global Cyclophosphamide Market Size by Type
4.1 Global Cyclophosphamide Historic Market Review by Type (2015-2020)
4.1.1 Global Cyclophosphamide Sales Market Share by Type (2015-2020)
4.1.2 Global Cyclophosphamide Revenue Market Share by Type (2015-2020)
4.1.3 Global Cyclophosphamide Price by Type (2015-2020)
4.2 Global Cyclophosphamide Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Cyclophosphamide Sales Forecast by Type (2021-2026)
4.2.2 Global Cyclophosphamide Revenue Forecast by Type (2021-2026)
4.2.3 Global Cyclophosphamide Price Forecast by Type (2021-2026)
5 Global Cyclophosphamide Market Size by Application
5.1 Global Cyclophosphamide Historic Market Review by Application (2015-2020)
5.1.1 Global Cyclophosphamide Sales Market Share by Application (2015-2020)
5.1.2 Global Cyclophosphamide Revenue Market Share by Application (2015-2020)
5.1.3 Global Cyclophosphamide Price by Application (2015-2020)
5.2 Global Cyclophosphamide Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Cyclophosphamide Sales Forecast by Application (2021-2026)
5.2.2 Global Cyclophosphamide Revenue Forecast by Application (2021-2026)
5.2.3 Global Cyclophosphamide Price Forecast by Application (2021-2026)
6 United States Cyclophosphamide Market Facts & Figures
6.1 United States Cyclophosphamide Sales Market Share by Company (2015-2020)
6.2 United States Cyclophosphamide Sales Market Share by Type (2015-2020)
6.3 United States Cyclophosphamide Sales Market Share by Application (2015-2020)
7 Europe Cyclophosphamide Market Facts & Figures
7.1 Europe Cyclophosphamide Sales Market Share by Company (2015-2020)
7.2 Europe Cyclophosphamide Sales Market Share by Type (2015-2020)
7.3 Europe Cyclophosphamide Sales Market Share by Application (2015-2020)
8 China Cyclophosphamide Market Facts & Figures
8.1 China Cyclophosphamide Sales Market Share by Company (2015-2020)
8.2 China Cyclophosphamide Sales Market Share by Type (2015-2020)
8.3 China Cyclophosphamide Sales Market Share by Application (2015-2020)
9 Japan Cyclophosphamide Market Facts & Figures
9.1 Japan Cyclophosphamide Sales Market Share by Company (3015-3030)
9.2 Japan Cyclophosphamide Sales Market Share by Type (2015-2020)
9.3 Japan Cyclophosphamide Sales Market Share by Application (2015-2020)
10 Southeast Asia Cyclophosphamide Market Facts & Figures
10.1 Southeast Asia Cyclophosphamide Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Cyclophosphamide Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Cyclophosphamide Sales Market Share by Application (2015-2020)
11 India Cyclophosphamide Market Facts & Figures
11.1 India Cyclophosphamide Sales Market Share by Company (2015-2020)
11.2 India Cyclophosphamide Sales Market Share by Type (2015-2020)
11.3 India Cyclophosphamide Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Cyclophosphamide Business
12.1 Baxter
12.1.1 Baxter Corporation Information
12.1.2 Baxter Business Overview
12.1.3 Baxter Cyclophosphamide Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Baxter Cyclophosphamide Products Offered
12.1.5 Baxter Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Cyclophosphamide Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Cyclophosphamide Products Offered
12.2.5 Novartis Recent Development
12.3 Hikma Pharmaceuticals
12.3.1 Hikma Pharmaceuticals Corporation Information
12.3.2 Hikma Pharmaceuticals Business Overview
12.3.3 Hikma Pharmaceuticals Cyclophosphamide Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Hikma Pharmaceuticals Cyclophosphamide Products Offered
12.3.5 Hikma Pharmaceuticals Recent Development
12.4 Amneal Pharmaceuticals LLC
12.4.1 Amneal Pharmaceuticals LLC Corporation Information
12.4.2 Amneal Pharmaceuticals LLC Business Overview
12.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Amneal Pharmaceuticals LLC Cyclophosphamide Products Offered
12.4.5 Amneal Pharmaceuticals LLC Recent Development
12.5 Jiangsu Hengrui Medicine
12.5.1 Jiangsu Hengrui Medicine Corporation Information
12.5.2 Jiangsu Hengrui Medicine Business Overview
12.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Jiangsu Hengrui Medicine Cyclophosphamide Products Offered
12.5.5 Jiangsu Hengrui Medicine Recent Development
12.6 NorthStar Rx LLC
12.6.1 NorthStar Rx LLC Corporation Information
12.6.2 NorthStar Rx LLC Business Overview
12.6.3 NorthStar Rx LLC Cyclophosphamide Sales, Revenue and Gross Margin (2015-2020)
12.6.4 NorthStar Rx LLC Cyclophosphamide Products Offered
12.6.5 NorthStar Rx LLC Recent Development
12.7 GLS Pharma
12.7.1 GLS Pharma Corporation Information
12.7.2 GLS Pharma Business Overview
12.7.3 GLS Pharma Cyclophosphamide Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GLS Pharma Cyclophosphamide Products Offered
12.7.5 GLS Pharma Recent Development
12.8 CSC Pharmaceuticals International
12.8.1 CSC Pharmaceuticals International Corporation Information
12.8.2 CSC Pharmaceuticals International Business Overview
12.8.3 CSC Pharmaceuticals International Cyclophosphamide Sales, Revenue and Gross Margin (2015-2020)
12.8.4 CSC Pharmaceuticals International Cyclophosphamide Products Offered
12.8.5 CSC Pharmaceuticals International Recent Development
13 Cyclophosphamide Manufacturing Cost Analysis
13.1 Cyclophosphamide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cyclophosphamide
13.4 Cyclophosphamide Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cyclophosphamide Distributors List
14.3 Cyclophosphamide Customers
15 Market Dynamics
15.1 Cyclophosphamide Market Trends
15.2 Cyclophosphamide Opportunities and Drivers
15.3 Cyclophosphamide Market Challenges
15.4 Cyclophosphamide Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Cyclophosphamide Sales (Person) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Cyclophosphamide Sales (Person) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Cyclophosphamide Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Cyclophosphamide Sales (Person) by Region (2015-2020)
Table 5. Global Cyclophosphamide Sales Market Share by Region (2015-2020)
Table 6. Global Cyclophosphamide Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Cyclophosphamide Revenue Share by Region (2015-2020)
Table 8. Global Cyclophosphamide Sales (Person) Forecast by Region (2021-2026)
Table 9. Global Cyclophosphamide Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Cyclophosphamide Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Cyclophosphamide Revenue Share Forecast by Region (2021-2026)
Table 12. Global Cyclophosphamide (Person) of Key Companies (2015-2020)
Table 13. Global Cyclophosphamide Sales Share by Company (2015-2020)
Table 14. Global Cyclophosphamide Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Cyclophosphamide Revenue Share by Company (2015-2020)
Table 16. Global Cyclophosphamide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclophosphamide as of 2019)
Table 17. Global Cyclophosphamide Average Price (Average Cost/Person) of Key Company (2015-2020)
Table 18. Manufacturers Cyclophosphamide Manufacturing Sites and Area Served
Table 19. Manufacturers Cyclophosphamide Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Cyclophosphamide Players
Table 22. Global Cyclophosphamide Sales (Person) by Type (2015-2020)
Table 23. Global Cyclophosphamide Sales Share by Type (2015-2020)
Table 24. Global Cyclophosphamide Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Cyclophosphamide Price (Person) by Type (2015-2020)
Table 26. Global Cyclophosphamide Sales Share by Type (2021-2026)
Table 27. Global Cyclophosphamide Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Cyclophosphamide Revenue Share by Type (2021-2026)
Table 29. Global Cyclophosphamide Price (Person) by Type (2021-2026)
Table 30. Global Cyclophosphamide Sales (Person) by Application (2015-2020)
Table 31. Global Cyclophosphamide Sales Share by Application (2015-2020)
Table 32. Global Cyclophosphamide Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Cyclophosphamide Price (Person) by Application (2015-2020)
Table 34. Global Cyclophosphamide Sales (Person) by Application (2021-2026)
Table 35. Global Cyclophosphamide Sales Share by Application (2021-2026)
Table 36. Global Cyclophosphamide Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Cyclophosphamide Revenue Share by Application (2021-2026)
Table 38. Global Cyclophosphamide Price (Person) by Application (2021-2026)
Table 39. United States Cyclophosphamide Sales (Person) by Company (2015-2020)
Table 40. United States Cyclophosphamide Sales Market Share by Company (2015-2020)
Table 41. United States Cyclophosphamide Sales (Person) by Type (2015-2020)
Table 42. United States Cyclophosphamide Sales Market Share by Type (2015-2020)
Table 43. United States Cyclophosphamide Sales (Person) by Application (2015-2020)
Table 44. United States Cyclophosphamide Sales Market Share by Application (2015-2020)
Table 45. Europe Cyclophosphamide Sales (Person) by Company (2015-2020)
Table 46. Europe Cyclophosphamide Sales Market Share by Company (2015-2020)
Table 47. Europe Cyclophosphamide Sales (Person) by Type (2015-2020)
Table 48. Europe Cyclophosphamide Sales Market Share by Type (2015-2020)
Table 49. Europe Cyclophosphamide Sales (Person) by Application (2015-2020)
Table 50. Europe Cyclophosphamide Sales Market Share by Type (2015-2020)
Table 51. China Cyclophosphamide Sales (Person) by Company (2015-2020)
Table 52. China Cyclophosphamide Sales Market Share by Company (2015-2020)
Table 53. China Cyclophosphamide Sales (Person) by Type (2015-2020)
Table 54. China Cyclophosphamide Sales Market Share by Type (2015-2020)
Table 55. China Cyclophosphamide Sales (Person) by Application (2015-2020)
Table 56. China Cyclophosphamide Sales Market Share by Application (2015-2020)
Table 57. Japan Cyclophosphamide Sales (Person) by Company (2015-2020)
Table 58. Japan Cyclophosphamide Sales Market Share by Company (2015-2020)
Table 59. Japan Cyclophosphamide Sales (Person) by Type (2015-2020)
Table 60. Japan Cyclophosphamide Sales Market Share by Type (2015-2020)
Table 61. Japan Cyclophosphamide Sales (Person) by Application (2015-2020)
Table 62. Japan Cyclophosphamide Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Cyclophosphamide Sales (Person) by Company (2015-2020)
Table 64. Southeast Asia Cyclophosphamide Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Cyclophosphamide Sales (Person) by Type (2015-2020)
Table 66. Southeast Asia Cyclophosphamide Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Cyclophosphamide Sales (Person) by Type (2015-2020)
Table 68. Southeast Asia Cyclophosphamide Sales Market Share by Application (2015-2020)
Table 69. India Cyclophosphamide Sales (Person) by Company (2015-2020)
Table 70. India Cyclophosphamide Sales Market Share by Company (2015-2020)
Table 71. India Cyclophosphamide Sales (Person) by Type (2015-2020)
Table 72. India Cyclophosphamide Sales Market Share by Type (2015-2020)
Table 73. India Cyclophosphamide Sales (Person) by Application (2015-2020)
Table 74. India Cyclophosphamide Sales Market Share by Application (2015-2020)
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Cyclophosphamide Sales (Person), Revenue (Million USD), Price (Average Cost/Person) and Gross Margin (2015-2020)
Table 78. Baxter Cyclophosphamide Product
Table 79. Baxter Recent Development
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Cyclophosphamide Sales (Person), Revenue (Million USD), Price (Average Cost/Person) and Gross Margin (2015-2020)
Table 83. Novartis Cyclophosphamide Product
Table 84. Novartis Recent Development
Table 85. Hikma Pharmaceuticals Corporation Information
Table 86. Hikma Pharmaceuticals Description and Business Overview
Table 87. Hikma Pharmaceuticals Cyclophosphamide Sales (Person), Revenue (Million USD), Price (Average Cost/Person) and Gross Margin (2015-2020)
Table 88. Hikma Pharmaceuticals Cyclophosphamide Product
Table 89. Hikma Pharmaceuticals Recent Development
Table 90. Amneal Pharmaceuticals LLC Corporation Information
Table 91. Amneal Pharmaceuticals LLC Description and Business Overview
Table 92. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Person), Revenue (Million USD), Price (Average Cost/Person) and Gross Margin (2015-2020)
Table 93. Amneal Pharmaceuticals LLC Cyclophosphamide Product
Table 94. Amneal Pharmaceuticals LLC Recent Development
Table 95. Jiangsu Hengrui Medicine Corporation Information
Table 96. Jiangsu Hengrui Medicine Description and Business Overview
Table 97. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Person), Revenue (Million USD), Price (Average Cost/Person) and Gross Margin (2015-2020)
Table 98. Jiangsu Hengrui Medicine Cyclophosphamide Product
Table 99. Jiangsu Hengrui Medicine Recent Development
Table 100. NorthStar Rx LLC Corporation Information
Table 101. NorthStar Rx LLC Description and Business Overview
Table 102. NorthStar Rx LLC Cyclophosphamide Sales (Person), Revenue (Million USD), Price (Average Cost/Person) and Gross Margin (2015-2020)
Table 103. NorthStar Rx LLC Cyclophosphamide Product
Table 104. NorthStar Rx LLC Recent Development
Table 105. GLS Pharma Corporation Information
Table 106. GLS Pharma Description and Business Overview
Table 107. GLS Pharma Cyclophosphamide Sales (Person), Revenue (Million USD), Price (Average Cost/Person) and Gross Margin (2015-2020)
Table 108. GLS Pharma Cyclophosphamide Product
Table 109. GLS Pharma Recent Development
Table 110. CSC Pharmaceuticals International Corporation Information
Table 111. CSC Pharmaceuticals International Cyclophosphamide Sales (Person), Revenue (Million USD), Price (Average Cost/Person) and Gross Margin (2015-2020)
Table 112. CSC Pharmaceuticals International Description and Business Overview
Table 113. CSC Pharmaceuticals International Cyclophosphamide Product
Table 114. CSC Pharmaceuticals International Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Cyclophosphamide Distributors List
Table 118. Cyclophosphamide Customers List
Table 119. Cyclophosphamide Market Key Trends
Table 120. Cyclophosphamide Key Opportunities and Drivers
Table 121. Cyclophosphamide Market Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Cyclophosphamide Product Picture
Figure 2. Global Cyclophosphamide Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cyclophosphamide Market Share by Application in 2020 & 2026
Figure 6. Cancer Examples
Figure 7. Autoimmune Diseases Examples
Figure 8. AL Amyloidosis Examples
Figure 9. Others Examples
Figure 10. Global Cyclophosphamide Sales (Person) Growth Rate (2015-2026)
Figure 11. Global Cyclophosphamide Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Cyclophosphamide Price Trends Growth Rate (2015-2026) (Average Cost/Person)
Figure 13. Global Cyclophosphamide Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Cyclophosphamide Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Cyclophosphamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Cyclophosphamide Sales (Person) Growth Rate (2015-2026)
Figure 17. Europe Cyclophosphamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Cyclophosphamide Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Cyclophosphamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Cyclophosphamide Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Cyclophosphamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Cyclophosphamide Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Cyclophosphamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Cyclophosphamide Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Cyclophosphamide Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Cyclophosphamide Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Cyclophosphamide Players Market Share by Revenue in Cyclophosphamide 2015 & 2019
Figure 28. Cyclophosphamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Cyclophosphamide Revenue Share by Type (2015-2020)
Figure 30. Global Cyclophosphamide Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Cyclophosphamide Revenue Share by Application (2015-2020)
Figure 32. Global Cyclophosphamide Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Cyclophosphamide Sales Market Share by Type in 2019
Figure 34. United States Cyclophosphamide Sales Market Share by Type in 2019
Figure 35. Europe Cyclophosphamide Sales Market Share by Company in 2019
Figure 36. Europe Cyclophosphamide Sales Market Share by Type in 2019
Figure 37. Europe Cyclophosphamide Sales Market Share by Application in 2019
Figure 38. China Cyclophosphamide Sales Market Share by Company in 2019
Figure 39. China Cyclophosphamide Sales Market Share by Type in 2019
Figure 40. China Cyclophosphamide Sales Market Share by Application in 2019
Figure 41. Japan Cyclophosphamide Sales Market Share by Company in 2019
Figure 42. Japan Cyclophosphamide Sales Market Share by Type in 2019
Figure 43. Japan Cyclophosphamide Sales Market Share by Application in 2019
Figure 44. Southeast Asia Cyclophosphamide Sales Market Share by Company in 2019
Figure 45. Southeast Asia Cyclophosphamide Sales Market Share by Type in 2019
Figure 46. Southeast Asia Cyclophosphamide Sales Market Share by Application in 2019
Figure 47. India Cyclophosphamide Sales Market Share by Company in 2019
Figure 48. India Cyclophosphamide Sales Market Share by Type in 2019
Figure 49. India Cyclophosphamide Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Cyclophosphamide
Figure 52. Manufacturing Process Analysis of Cyclophosphamide
Figure 53. Cyclophosphamide Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
デジタル定量吸入器の世界市場レポート2020 Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. Market Analysis and Insights: Global Digital Dose Inhaler Market The global Digital Dose Inhaler market size is projected to reach US$ 2510.9 million by 2026, from…- 定量吸入器の世界市場レポート2020 Market Analysis and Insights: Global Metered Dose Inhalers Market The global Metered Dose Inhalers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Metered Dose Inhalers Scope and Market Size The global Metered Dose Inha…
- 加圧式定量吸入器の世界市場レポート2020 Market Analysis and Insights: Global Pressurized Metered-dose Inhaler Market The global Pressurized Metered-dose Inhaler market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Pressurized Metered-dose Inhaler Scope and Market …
- N-アセチルシステインの世界市場レポート2020 Market Analysis and Insights: Global N-acetylcysteine (CAS 616-91-1) Market The global N-acetylcysteine (CAS 616-91-1) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global N-acetylcysteine (CAS 616-91-1) Scope and Market Siz…
- ピルオーガナイザーの世界市場レポート2020 Market Analysis and Insights: Global Pill Organisers Market The global Pill Organisers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Pill Organisers Scope and Market Size The global Pill Organisers market is segmented…